why choose us

First received: July 28, 2023

Clinical Trial: Brain Slice Explants to Predict Drug Response in Brain Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Central Nervous System Tumor

Study Type: OBSERVATIONAL


Official Title: A Feasibility Study to Determine if a Novel Patient-derived Explant Platform Can Produce Drug Sensitivity Scores Within a Clinically Relevant Time Frame in Patients With CNS Tumors

Brief Summary: This biospecimen collection study will evaluate the feasibility of engrafting and testing resected Central nervous system (CNS) tumors tumor tissue ex vivo to estimate drug response, in pediatric and adult subjects.CNS tumors display remarkable heterogeneity and unfortunately there are no reliable precision oncology platforms that can identify the most effective therapy for each patient.Recent work has demonstrated the success of functional precision oncology platforms using patient-derived explant (PDE) at…

Read more